Fatty acid treatment

A method for increasing the systemic calcium pool by stimulating both an increased absorption of and a reduction of urinary excretion of calcium in humans or animals, said method comprising administering GLA or DGLA as such or in salt form other than the calcium salt or in other pharmacologically acceptable form convertible thereto in the body, optionally in association with EPA, DHA or other essential fatty acid of the n-3 or n-6 series additional to the GLA or DGLA as such or in salt or other pharmacologically acceptable form convertible thereto in the body.

A method for treating humans or animals having inadequate gut calcium absorption thereby increasing gut calcium absorption in humans or animals, said method comprising administering to said humans or animals gamma-linolenic acid (GLA) or dihomo-gamma-linolenic acid (DGLA) as such or in salt form other than the calcium salt or in other pharmacologically acceptable form convertible thereto in the body together with eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) or other essential fatty acid of the n-3 or n-6 series additional to the GLA or DGLA as a calcium salt or other pharmacologically acceptable form convertible thereto in the body.

A method for increasing the systemic calcium pool by stimulating both an increased absorption of and a reduction of urinary excretion of calcium in humans or animals suffering from low calcium absorption by administering GLA or DGLA to said humans or animals as such or in salt form other than the calcium salt or in other pharmacologically acceptable form convertible thereto in the body, optionally in association with EPA, DHA or other essential fatty acid of the n-3 or n-6 series additional to the GLA or DGLA as a calcium salt or other pharmacologically acceptable form convertible thereto in the body.